Inventor
PASCHON DAVID
US50 patents
⚠️ This page may combine multiple inventors who share the name “PASCHON DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SANGAMO BIOSCIENCES INC
22 patentsUS9567609B2Feb 14, 2017
Compositions for linking DNA-binding domains and cleavage domains
SANGAMO BIOSCIENCES INC41 citations98
US9458205B2Oct 4, 2016
Modified DNA-binding proteins and uses thereof
SANGAMO BIOSCIENCES INC87 citations98
US9937207B2Apr 10, 2018
Targeted disruption of T cell receptor genes using talens
SANGAMO BIOSCIENCES INC37 citations92
US9222105B2Dec 29, 2015
Methods and compositions for modification of the HPRT locus
SANGAMO BIOSCIENCES INC16 citations92
US8912138B2Dec 16, 2014
DNA-binding proteins and uses thereof
SANGAMO BIOSCIENCES INC14 citations92
US10081661B2Sep 25, 2018
Methods and compositions for genome engineering
SANGAMO BIOSCIENCES INC9 citations84
US9771403B2Sep 26, 2017
Methods and compositions for treating hemophilia
SANGAMO BIOSCIENCES INC8 citations84
US9493750B2Nov 15, 2016
DNA-binding proteins and uses thereof
SANGAMO BIOSCIENCES INC4 citations84
US9322005B2Apr 26, 2016
DNA-binding proteins and uses thereof
SANGAMO BIOSCIENCES INC6 citations84
US9163245B2Oct 20, 2015
Compositions for linking zinc finger modules
SANGAMO BIOSCIENCES INC13 citations84
US8895264B2Nov 25, 2014
Methods and compositions for modification of the HPRT locus
SANGAMO BIOSCIENCES INC10 citations84
US10046028B2Aug 14, 2018
Methods and compositions for modulating PD1
SANGAMO BIOSCIENCES INC7 citations83
US10724020B2Jul 28, 2020
Compositions for linking DNA-binding domains and cleavage domains
SANGAMO BIOSCIENCES INC2 citations73
US9963715B2May 8, 2018
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC3 citations73
US9783827B2Oct 10, 2017
DNA-binding proteins and uses thereof
SANGAMO BIOSCIENCES INC2 citations73
US9650648B2May 16, 2017
Methods and compositions for treatment of a genetic condition
SANGAMO BIOSCIENCES INC4 citations73
US10435441B2Oct 8, 2019
HTT repressors and uses thereof
SANGAMO BIOSCIENCES INC4 citations72
US10155011B2Dec 18, 2018
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
SANGAMO BIOSCIENCES INC4 citations72
US9402879B2Aug 2, 2016
Methods and compositions for modulating PD1
SANGAMO BIOSCIENCES INC2 citations62
US9267154B2Feb 23, 2016
Targeted integration into the PPP1R12C locus
SANGAMO BIOSCIENCES INC2 citations62
US11352631B2Jun 7, 2022
Targeted disruption of the T cell receptor
SANGAMO BIOSCIENCES INC0 citations52
US9914940B2Mar 13, 2018
Targeted integration into the PPP1R12C locus
SANGAMO BIOSCIENCES INC0 citations51
SANGAMO THERAPEUTICS INC
20 patentsUS10500229B2Dec 10, 2019
Targeted disruption of the MHC cell receptor
SANGAMO THERAPEUTICS INC6 citations84
US10407476B2Sep 10, 2019
Methods and compositions for treating hemophilia
SANGAMO THERAPEUTICS INC4 citations84
US10253333B2Apr 9, 2019
DNA-binding proteins and uses thereof
SANGAMO THERAPEUTICS INC5 citations84
US11661612B2May 30, 2023
DNA-binding proteins and uses thereof
SANGAMO THERAPEUTICS INC1 citations73
US10968261B2Apr 6, 2021
Methods and compositions for genome engineering
SANGAMO THERAPEUTICS INC2 citations73
US10960085B2Mar 30, 2021
Modulation of liver genes
SANGAMO THERAPEUTICS INC3 citations73
US10538787B2Jan 21, 2020
Compositions for linking DNA-binding domains and cleavage domains
SANGAMO THERAPEUTICS INC1 citations73
US11123443B2Sep 21, 2021
Htt repressors and uses thereof
SANGAMO THERAPEUTICS INC2 citations72
US11920169B2Mar 5, 2024
Compositions for linking DNA-binding domains and cleavage domains
SANGAMO THERAPEUTICS INC0 citations63
US11634463B2Apr 25, 2023
Methods and compositions for treating hemophilia
SANGAMO THERAPEUTICS INC0 citations63
US11041174B2Jun 22, 2021
Compositions for linking DNA-binding domains and cleavage domains
SANGAMO THERAPEUTICS INC0 citations63
US12551575B2Feb 17, 2026
Htt repressors and uses thereof
SANGAMO THERAPEUTICS INC0 citations62
US12043650B2Jul 23, 2024
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
SANGAMO THERAPEUTICS INC0 citations62
US11492643B2Nov 8, 2022
Methods and compositions for treatment of a genetic condition
SANGAMO THERAPEUTICS INC0 citations62
US11439666B2Sep 13, 2022
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
SANGAMO THERAPEUTICS INC0 citations62
US11285175B2Mar 29, 2022
Targeted disruption of the MHC cell receptor
SANGAMO THERAPEUTICS INC0 citations62
US11235026B2Feb 1, 2022
Methods and compositions for modulating PD1
SANGAMO THERAPEUTICS INC1 citations62
US10918668B2Feb 16, 2021
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
SANGAMO THERAPEUTICS INC1 citations60
US11649468B2May 16, 2023
Targeted integration into the PPP1R12C locus
SANGAMO THERAPEUTICS INC0 citations58
US11512287B2Nov 29, 2022
Targeted disruption of T cell and/or HLA receptors
SANGAMO THERAPEUTICS INC0 citations49